
Get Cash Back and $0 Commissions
+ The Power of TradeStation
Business Wire 5-Feb-2026 6:00 AM
Delivered Strong Fiscal 2026 Second Quarter and First Half Results across Sales, Margins and EPS
Raising Fiscal 2026 Full-Year Outlook
The Estée Lauder Companies Inc. (NYSE:EL) today reported its financial results for the second quarter ended December 31, 2025.
"We delivered excellent second quarter results to solidify a strong first half of fiscal 2026," said Stéphane de La Faverie, President and CEO. "In this pivotal year, Beauty Reimagined has invigorated our business as we execute the biggest operational, leadership, and cultural transformation in our history. On its one-year anniversary, we raise our fiscal 2026 outlook confident in the strength of our turnaround, even as our second half reflects previously-expected headwinds and now-greater consumer-facing investments, as we expect to restore organic sales growth and expand our operating margin for the first time in four years."
FISCAL 2026 SECOND QUARTER SELECT FINANCIAL RESULTS (unaudited)1,2,3
|
Three Months Ended December 31 |
Percentage Change |
||||||
($ in millions, except per share data) |
2025 |
2024 |
||||||
Net Sales |
$ |
4,229 |
|
$ |
4,004 |
|
6 |
% |
Organic Net Sales, Non-GAAP1,2 |
$ |
4,155 |
|
$ |
4,004 |
|
4 |
% |
Other Financial Results: |
|
|
|
|||||
Gross Profit |
$ |
3,235 |
|
$ |
3,047 |
|
6 |
% |
Gross Margin |
|
76.5 |
% |
|
76.1 |
% |
|
|
Adjusted Gross Profit, Non-GAAP1,3 |
$ |
3,235 |
|
$ |
3,047 |
|
6 |
% |
Adjusted Gross Margin, Non-GAAP1,3 |
|
76.5 |
% |
|
76.1 |
% |
|
|
|
|
|
|
|||||
Operating Income (Loss) |
$ |
401 |
|
$ |
(580 |
) |
100 |
+% |
Operating Margin |
|
9.5 |
% |
|
(14.5 |
)% |
|
|
Adjusted Operating Income, Non-GAAP1,3 |
$ |
608 |
|
$ |
462 |
|
32 |
% |
Adjusted Operating Margin, Non-GAAP1,3 |
|
14.4 |
% |
|
11.5 |
% |
|
|
|
|
|
|
|||||
Diluted Net Earnings (Loss) Per Common Share |
$ |
.44 |
|
$ |
(1.64 |
) |
100 |
+% |
Adjusted Diluted Net Earnings Per Common Share, Non-GAAP1,3 |
$ |
.89 |
|
$ |
.62 |
|
43 |
% |
| 1See pages 18 and 19 for reconciliation between GAAP and Adjusted Non-GAAP measures. | |
| 2Organic net sales represents net sales excluding returns associated with restructuring and other activities; non-comparable impacts of acquisitions, divestitures and brand closures; as well as the impact from foreign currency translation. The Company believes that the Non-GAAP measure of organic net sales growth provides year-over-year sales comparisons on a consistent basis. | |
| 3Adjusted Non-GAAP measures are calculated based on Net Sales adjusted only for Returns associated with restructuring and other activities. | |
| 4Consumer-facing investments includes co-operative advertising, selling, advertising and promotional expenses, as well as store operating costs. | |
| 5Free Cash Flow is defined as net cash flows from operating activities less capital expenditures. See page 21 for the reconciliation between GAAP and Adjusted Non-GAAP measures. | |
BEAUTY GAINS AND OPERATIONAL HIGHLIGHTS6
| 6Since the Company's last earnings announcement, including some previously disclosed. | |
| 7Source, excluding direct-to-consumer data: Circana, LLC, US Prestige Beauty Total Department/Specialty, Dollar Share Growth of Corporation, three-months ended December 31, 2025. | |
Announced in February 2026 a pioneering collaboration in the U.S. between Clinique and ACUVUE, a globally trusted contact lens brand, uniting two global leaders around a mission to advance eye education in beauty and vision by highlighting to consumers that they can wear contacts and eye makeup confidently
FISCAL 2026 SECOND QUARTER RESULTS BY PRODUCT CATEGORY AND BY REGION
Results by Product Category |
||||||||||||||||||||
(Unaudited) |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
|
Three Months Ended December 31 |
|||||||||||||||||||
|
Net Sales |
Percentage Change1 |
Operating Income (Loss) |
Percentage Change |
||||||||||||||||
($ in millions) |
2025 |
2024 |
Reported Basis |
Impact of Foreign Currency Translation |
Organic Net Sales (Non-GAAP) |
2025 |
2024 |
Reported Basis |
||||||||||||
Skin Care |
$ |
2,054 |
$ |
1,921 |
7 |
% |
(1 |
)% |
6 |
% |
$ |
454 |
|
$ |
306 |
|
48 |
% |
||
Makeup |
|
1,164 |
|
|
1,150 |
|
1 |
|
(2 |
) |
(1 |
) |
|
18 |
|
|
(211 |
) |
100 |
+ |
Fragrance |
|
812 |
|
|
744 |
|
9 |
|
(3 |
) |
6 |
|
|
105 |
|
|
(446 |
) |
100 |
+ |
Hair Care |
|
168 |
|
|
159 |
|
6 |
|
(1 |
) |
5 |
|
|
18 |
|
|
(3 |
) |
100 |
+ |
Other |
|
31 |
|
|
30 |
|
3 |
|
— |
|
3 |
|
|
13 |
|
|
(45 |
) |
100 |
+ |
Subtotal |
$ |
4,229 |
|
$ |
4,004 |
|
6 |
% |
(2 |
)% |
4 |
% |
$ |
608 |
|
$ |
(399 |
) |
100 |
+% |
Returns/charges |
|
|
|
|
||||||||||||||||
associated with |
|
|
|
|
||||||||||||||||
restructuring and |
|
|
|
|
||||||||||||||||
other activities |
|
— |
|
|
— |
|
|
|
|
|
(207 |
) |
|
(181 |
) |
|
||||
Total |
$ |
4,229 |
|
$ |
4,004 |
|
6 |
% |
(2 |
)% |
4 |
% |
$ |
401 |
|
$ |
(580 |
) |
100 |
+% |
Non-GAAP Adjustments to As Reported Operating Income (Loss): |
||||||||||||||||||||
Returns/charges associated with restructuring and other activities |
|
207 |
|
|
181 |
|
|
|||||||||||||
Makeup - Goodwill and other intangible asset impairments |
|
— |
|
|
258 |
|
|
|||||||||||||
Fragrance - Other intangible asset impairments |
|
— |
|
|
549 |
|
|
|||||||||||||
Other - Other intangible asset impairments |
|
— |
|
|
54 |
|
|
|||||||||||||
Adjusted Operating Income - Non-GAAP |
$ |
608 |
|
$ |
462 |
|
32 |
% |
||||||||||||
1Percentages are calculated on an individual basis. |
||||||||||||||||||||
The product category net sales commentary below reflects organic net sales, excluding the favorable impacts from foreign currency translation. In addition to the Operational Highlights above, below are the drivers of the Company's performance.
Skin Care
Makeup
Fragrance
Hair Care
Results by Geographic Region |
||||||||||||||||||||
(Unaudited) |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
|
Three Months Ended December 31 |
|||||||||||||||||||
|
Net Sales |
Percentage Change1 |
Operating Income (Loss)2 |
Percentage Change |
||||||||||||||||
($ in millions) |
2025 |
2024 |
Reported Basis |
Impact of Foreign Currency Translation |
Organic Net Sales (Non-GAAP) |
2025 |
2024 |
Reported Basis |
||||||||||||
The Americas |
$ |
1,218 |
$ |
1,209 |
1 |
% |
— |
% |
— |
% |
$ |
104 |
|
$ |
(771 |
) |
100 |
+% |
||
EUKEM |
|
1,183 |
|
|
1,085 |
|
9 |
|
(7 |
) |
2 |
|
|
156 |
|
|
145 |
|
8 |
|
Asia/Pacific |
|
900 |
|
|
888 |
|
1 |
|
1 |
|
2 |
|
|
200 |
|
|
152 |
|
32 |
|
Mainland China |
|
928 |
|
|
822 |
|
13 |
|
— |
|
13 |
|
|
148 |
|
|
75 |
|
97 |
|
Subtotal |
$ |
4,229 |
|
$ |
4,004 |
|
6 |
% |
(2 |
)% |
4 |
% |
$ |
608 |
|
$ |
(399 |
) |
100 |
+% |
Returns/charges |
|
|
|
|
||||||||||||||||
associated with |
|
|
|
|
||||||||||||||||
restructuring and other |
|
|
|
|
||||||||||||||||
activities |
|
— |
|
|
— |
|
|
|
|
|
(207 |
) |
|
(181 |
) |
|
||||
Total |
$ |
4,229 |
|
$ |
4,004 |
|
6 |
% |
(2 |
)% |
4 |
% |
$ |
401 |
|
$ |
(580 |
) |
100 |
+% |
Non-GAAP Adjustments to As Reported Operating Income (Loss): |
||||||||||||||||||||
Returns/charges associated with restructuring and other activities |
|
207 |
|
|
181 |
|
|
|||||||||||||
The Americas - Goodwill and other intangible asset impairments |
|
— |
|
|
861 |
|
|
|||||||||||||
Adjusted Operating Income - Non-GAAP |
$ |
608 |
|
$ |
462 |
|
32 |
% |
||||||||||||
1Percentages are calculated on an individual basis. |
||||||||||||||||||||
2As previously disclosed, operating results by geographic region for the fiscal 2025 second quarter (quarter-to-date period) have been adjusted to reflect the correction of a regional misclassification in the amounts furnished in the Form 8-K on October 2, 2025 related to a one-time charge during the fiscal 2025 first quarter. The misclassification was offset in the fiscal 2025 first quarter furnished amounts. No other periods were impacted and there is no impact on the consolidated financial results or results by product category. |
||||||||||||||||||||
The geographic region net sales commentary below reflects organic net sales, excluding the (favorable)/unfavorable impacts from foreign currency translation. In addition to the Operational Highlights above, below are the drivers of the Company's performance.
Organic Net Sales - increased 4%, led by:
Operating Results - increased to income compared to a loss in the prior-year period, driven by:
QUARTERLY DIVIDEND Today, the Company announced a quarterly dividend of $.35 per share on its Class A and Class B Common Stock, payable in cash on March 16, 2026 to stockholders of record at the close of business on February 27, 2026.
PROFIT RECOVERY AND GROWTH PLAN ("PRGP") In November 2025, the Company approved initiatives under the restructuring program component of the PRGP and entered into an agreement with Accenture for Enterprise Business Services ("EBS") in connection with the transformation of its global operating model. See below for additional details.
Actions under the Company's PRGP are still expected to be substantially completed in fiscal 2027, with a majority of the full run-rate benefits still expected to be realized during fiscal 2027. The plan is designed to further transform the Company's operating model to fund a return to sales growth in fiscal 2026 and restore a solid double-digit adjusted operating margin over the next few years, as well as continue to mitigate impacts from external volatility.
Restructuring Program Component of the PRGP The Company entered into a strategic agreement for EBS in connection with the transformation of its global operating model through the (i) consolidation of certain service providers, (ii) expansion of outsourced services, and (iii) redesign and standardization of the related end-to-end business processes, leveraging advanced technology to improve productivity. These actions will primarily result in other charges, including professional services related to the design, implementation and execution of the initiative. These charges include transition and transformation support, process design, and costs to support the global project management office for this initiative. These actions will also result in employee severance through a net reduction in workforce and contract termination charges. The Company expects these initiatives to yield net benefits, ramping up over time, as the transition progresses, normalized service levels are achieved and operational scale and efficiencies are realized. The Company remains on track to achieve the overall PRGP savings.
Relating specifically to the restructuring program component of the PRGP, once fully implemented, the Company still expects to take restructuring and other charges of between $1.2 billion and $1.6 billion, before taxes, consisting of employee-related costs, asset-related costs, contract terminations and other costs associated with implementing these initiatives. The restructuring program is still expected to yield annual gross benefits of between $0.8 billion and $1.0 billion, before taxes, to help restore operating margin and also fuel reinvestment in consumer-facing areas to drive sustainable sales growth.
The Company still estimates a net reduction in positions of 5,800 to 7,000, including approvals to date. This net reduction takes into account the elimination of positions after retraining and redeployment of certain employees in select areas. Approvals for specific initiatives under this restructuring program, in total, are expected to be completed by the end of fiscal 2026. The restructuring program's focus includes the (i) reorganization and rightsizing of certain areas, (ii) simplification and acceleration of processes, (iii) outsourcing of select services and (iv) evolution of go-to-market footprint and selling models.
Through December 31, 2025, the Company has recognized total cumulative charges under the restructuring component of the PRGP of $904 million, consisting primarily of employee-related costs. For the three and six months ended December 31, 2025, the Company recognized charges of $207 million and $294 million, respectively.
Through January 30, 2026, the Company has approved initiatives totaling cumulative charges of $1.2 billion and a net reduction of over 6,000 positions. Inclusive of approvals through January 30, 2026, and relative to the high end of the total expected ranges, the Company has approved initiatives that account for over 80% of the expected gross benefits, over 75% of the expected charges and over 80% of the expected net reduction in positions.
OUTLOOK FOR FISCAL 2026 FULL YEAR The Company is raising its fiscal 2026 full-year outlook, reflecting solid performance in the fiscal 2026 first half while remaining cautious amid ongoing macroeconomic uncertainty and continued headwinds in key areas of its business. Accordingly, the Company is tightening the range on net sales and raising its outlook for adjusted diluted net earnings per common share and adjusted operating margin.
The Company continues to closely monitor evolving trade policies and enacted tariffs, actively evaluating developments and mitigation strategies to reduce the potential impacts of tariffs. The Company has implemented a range of actions, including leveraging available trade programs and further optimizing its regional manufacturing footprint to bring production closer to the consumer—including through its facility in Japan. These efforts, combined with increased supply chain agility, are helping to offset more than half of the expected impacts and better position the Company to adapt quickly as trade policies continue to evolve.
In terms of enacted tariffs, the Company's assumption continues to reflect the following incremental rates on its most material flow of goods:
Based on information available and net of planned mitigation actions through January 29, 2026, the Company continues to expect tariff-related headwinds to impact fiscal 2026 profitability by approximately $100 million, mostly in the second half. This assumption does not reflect any subsequent or future changes. The Company continues to evaluate additional strategies, including further PRGP initiatives and potential pricing actions.
Reconciliation between GAAP and Non-GAAP - Net Sales Growth |
||
(Unaudited) |
||
|
|
|
|
Twelve Months Ending |
|
|
June 30, 2026(1) |
|
As Reported - GAAP |
3% - 5 |
% |
Impact of foreign currency translation |
2 |
|
Returns associated with restructuring and other activities(2) |
— |
|
Organic, Non-GAAP |
1% - 3 |
% |
(1)Represents forecast, using spot rates as of December 31, 2025. |
||
(2)The net sales growth impact of returns associated with restructuring and other activities includes approvals to date. Additional returns associated with restructuring and other activities are anticipated as initiatives are approved in fiscal 2026. |
||
Reconciliation between GAAP and Non-GAAP - Diluted Net Earnings (Loss) Per Common Share ("EPS") |
|||||||
(Unaudited) |
|||||||
|
|
|
|
||||
|
Twelve Months Ending |
||||||
|
June 30 |
|
|||||
|
2026(1) |
2025 |
Growth |
||||
Forecasted/As Reported EPS - GAAP |
$.98 - $1.22 |
$ |
(3.15 |
) |
100 |
+% |
|
|
|
|
|
||||
Non-GAAP |
|
|
|
||||
Restructuring and other charges(2) |
1.03 - 1.07 |
|
1.06 |
|
|
||
Goodwill and other intangible asset impairments |
— |
|
|
2.78 |
|
|
|
U.S. deferred tax asset valuation allowance adjustment |
— |
|
|
.48 |
|
|
|
Talcum litigation settlement agreements(3) |
— |
|
|
.34 |
|
|
|
Forecasted/Adjusted EPS - Non-GAAP |
$2.05 - $2.25 |
$ |
1.51 |
|
36% - 49 |
% |
|
Impact of foreign currency translation |
(.02 |
) |
|
||||
Forecasted/Adjusted Constant Currency EPS - Non-GAAP |
$2.03 - $2.23 |
$ |
1.51 |
|
35% - 48 |
% |
|
(1)Represents forecast, using spot rates as of December 31, 2025. |
|||||||
(2)The diluted net earnings per common share impact of restructuring and other charges includes approvals to date. Additional restructuring and other charges are anticipated as initiatives are approved in fiscal 2026. |
|||||||
(3)No assumptions included in the fiscal 2026 forecast. |
|||||||
The Company's fiscal 2026 full-year outlook reflects the following:
The Company continues to monitor the effects of the global macro environment, including the risk of recession; currency volatility; inflationary pressures; supply chain challenges; social and political issues; competitive pressures; legal and regulatory matters, including the imposition of tariffs and sanctions; geopolitical tensions; and global security issues. The Company is also mindful of inflationary pressures (including those caused by tariffs) on its cost base and is monitoring the impact on consumer preferences, the impact of changes being made in the organization, including those related to Beauty Reimagined and the PRGP, as well as the potential impact of changes expected to be made as part of the PRGP on suppliers, retailers and others, and challenges relating to successfully outsourcing select services.
CONFERENCE CALL AND WEBCAST DETAILS The Estée Lauder Companies will host a conference call at 8:30 a.m. (ET) today, February 5, 2026 to discuss its results for the fiscal 2026 second quarter. The dial-in number for the call is 877-883-0383 in the U.S. or 412-902-6506 internationally (conference ID number: 1156365).
The call will also be webcast live at http://www.elcompanies.com/investors/events-and-presentations and will be available for replay until February 19, 2026.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS Statements in this press release, in particular those in "Outlook," as well as remarks by the CEO and other members of management, may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may address the Company's expectations regarding sales, earnings or other future financial performance and liquidity, other performance measures, product introductions, entry into new geographic regions, information technology initiatives, new methods of sale, the Company's long-term strategy, restructuring and other charges and resulting cost savings, and future operations or operating results. These statements may contain words like "expect," "will," "will likely result," "would," "believe," "estimate," "planned," "plans," "intends," "may," "should," "could," "anticipate," "estimate," "project," "projected," "forecast," and "forecasted" or similar expressions. Although the Company believes that its expectations are based on reasonable assumptions within the bounds of its knowledge of its business and operations, actual results may differ materially from the Company's expectations. Factors that could cause actual results to differ from expectations include, without limitation:
| (1) | increased competitive activity from companies in the skin care, makeup, fragrance and hair care businesses; |
|
| (2) | the Company's ability to develop, produce and market new products on which future operating results may depend and to successfully address challenges in the Company's business; |
|
| (3) | consolidations, restructurings, bankruptcies and reorganizations in the retail industry causing a decrease in the number of stores that sell the Company's products, an increase in the ownership concentration within the retail industry, ownership of retailers by the Company's competitors or ownership of competitors by the Company's customers that are retailers and the Company's inability to collect receivables; |
|
| (4) | destocking and tighter working capital management by retailers; |
|
| (5) | the success, or changes in timing or scope, of new product launches and the success, or changes in timing or scope, of advertising, sampling and merchandising programs; |
|
| (6) | shifts in the preferences of consumers as to how they perceive value and where and how they shop; |
|
| (7) | social, political and economic risks to the Company's foreign or domestic manufacturing, distribution and retail operations, including changes in foreign investment and trade policies and regulations of the host countries and of the United States; |
|
| (8) | changes in the laws, regulations and policies (including the interpretations and enforcement thereof) that affect, or will affect, the Company's business, including those relating to its products or distribution networks, changes in accounting standards, tax laws and regulations, environmental or climate change laws, regulations or accords, trade rules and customs regulations, and the outcome and expense of legal or regulatory proceedings, and any action the Company may take as a result; |
|
| (9) | foreign currency fluctuations affecting the Company's results of operations and the value of its foreign assets, the relative prices at which the Company and its foreign competitors sell products in the same markets and the Company's operating and manufacturing costs outside of the United States; |
|
| (10) | changes in global or local conditions, including those due to volatility in the global credit and equity markets, government economic policies, natural or man-made disasters, real or perceived epidemics, supply chain challenges, inflation, or increased energy costs, that could affect consumer purchasing, the willingness or ability of consumers to travel and/or purchase the Company's products while traveling, the financial strength of the Company's customers, suppliers or other contract counterparties, the Company's operations, the cost and availability of capital which the Company may need for new equipment, facilities or acquisitions, the returns that the Company is able to generate on its pension assets and the resulting impact on funding obligations, the cost and availability of raw materials and the assumptions underlying the Company's critical accounting estimates; |
|
| (11) | shipment delays, commodity pricing, depletion of inventory and increased production costs resulting from disruptions of operations at any of the facilities that manufacture the Company's products or at the Company's distribution or inventory centers, including disruptions that may be caused by the implementation of information technology initiatives, or by restructurings; |
|
| (12) | real estate rates and availability, which may affect the Company's ability to increase or maintain the number of retail locations at which the Company sells its products and the costs associated with the Company's other facilities; |
|
| (13) | changes in product mix to products which are less profitable; |
|
| (14) | the Company's ability to acquire, develop or implement new information technology, including operational technology and websites, on a timely basis and within the Company's cost estimates; to maintain continuous operations of its new and existing information technology; and to secure the data and other information that may be stored in such technologies or other systems or media; |
|
| (15) | the Company's ability to capitalize on opportunities for improved efficiency, such as publicly-announced strategies and restructuring and cost-savings initiatives, and to integrate acquired businesses and realize value therefrom; |
|
| (16) | consequences attributable to local or international conflicts around the world, as well as from any terrorist action, retaliation and the threat of further action or retaliation; |
|
| (17) | the timing and impact of acquisitions, investments and divestitures; and |
|
| (18) | additional factors as described in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended June 30, 2025. |
The Company assumes no responsibility to update forward-looking statements made herein or otherwise.
The Estée Lauder Companies Inc. is one of the world's leading manufacturers, marketers and sellers of quality skin care, makeup, fragrance and hair care products, and is a steward of luxury and prestige brands globally. The Company's products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown Cosmetics, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, the DECIEM family of brands, including The Ordinary and NIOD, and BALMAIN Beauty.
ELC-F ELC-E
CONSOLIDATED STATEMENT OF EARNINGS (LOSS) |
|||||||||||||||||
(Unaudited) |
|||||||||||||||||
|
|
|
|
|
|
|
|
||||||||||
|
Three Months Ended December 31 |
Percentage Change |
|
Six Months Ended December 31 |
Percentage Change |
||||||||||||
($ in millions, except per share data) |
2025 |
2024 |
|
2025 |
2024 |
||||||||||||
Net sales(A) |
$ |
4,229 |
|
$ |
4,004 |
|
6 |
% |
|
$ |
7,710 |
|
$ |
7,365 |
|
5 |
% |
Cost of sales(A) |
|
994 |
|
|
957 |
|
4 |
|
|
|
1,921 |
|
|
1,885 |
|
2 |
|
Gross profit |
|
3,235 |
|
|
3,047 |
|
6 |
|
|
|
5,789 |
|
|
5,480 |
|
6 |
|
Gross margin |
|
76.5 |
% |
|
76.1 |
% |
|
|
|
75.1 |
% |
|
74.4 |
% |
|
||
Operating expenses |
|
|
|
|
|
|
|
||||||||||
Selling, general and administrative |
|
2,627 |
|
|
2,585 |
|
2 |
|
|
|
4,923 |
|
|
4,883 |
|
1 |
|
Restructuring and other charges(A) |
|
207 |
|
|
181 |
|
14 |
|
|
|
296 |
|
|
278 |
|
6 |
|
Impairment of goodwill and other intangible assets(B) |
|
— |
|
|
861 |
|
(100 |
) |
|
|
— |
|
|
861 |
|
(100 |
) |
Talcum litigation settlement agreements(C) |
|
— |
|
|
— |
|
— |
|
|
|
— |
|
|
159 |
|
(100 |
) |
Total operating expenses |
|
2,834 |
|
|
3,627 |
|
(22 |
) |
|
|
5,219 |
|
|
6,181 |
|
(16 |
) |
Operating expense margin |
|
67.0 |
% |
|
90.6 |
% |
|
|
|
67.7 |
% |
|
83.9 |
% |
|
||
Operating income (loss) |
|
401 |
|
|
(580 |
) |
100 |
+ |
|
|
570 |
|
|
(701 |
) |
100 |
+ |
Operating income (loss) margin |
|
9.5 |
% |
|
(14.5 |
)% |
|
|
|
7.4 |
% |
|
(9.5 |
)% |
|
||
Interest expense |
|
85 |
|
|
90 |
|
(6 |
) |
|
|
171 |
|
|
182 |
|
(6 |
) |
Interest income and investment income, net |
|
21 |
|
|
23 |
|
(9 |
) |
|
|
51 |
|
|
58 |
|
(12 |
) |
Other components of net periodic benefit cost |
|
4 |
|
|
3 |
|
33 |
|
|
|
8 |
|
|
5 |
|
60 |
|
Earnings (loss) before income taxes |
|
333 |
|
|
(650 |
) |
100 |
+ |
|
|
442 |
|
|
(830 |
) |
100 |
+ |
Provision (benefit) for income taxes |
|
171 |
|
|
(60 |
) |
100 |
+ |
|
|
233 |
|
|
(84 |
) |
100 |
+ |
Net earnings (loss) |
$ |
162 |
|
$ |
(590 |
) |
100 |
+% |
|
$ |
209 |
|
$ |
(746 |
) |
100 |
+% |
|
|
|
|
|
|
|
|
||||||||||
Net earnings (loss) per common share |
|
|
|
|
|
|
|
||||||||||
Basic |
$ |
.45 |
|
$ |
(1.64 |
) |
100 |
+% |
|
$ |
.58 |
|
$ |
(2.07 |
) |
100 |
+% |
Diluted |
$ |
.44 |
|
$ |
(1.64 |
) |
100 |
+% |
|
$ |
.57 |
|
$ |
(2.07 |
) |
100 |
+% |
|
|
|
|
|
|
|
|
||||||||||
Weighted-average common shares outstanding |
|
|
|
|
|
|
|
||||||||||
Basic |
|
362.1 |
|
|
360.0 |
|
|
|
|
361.7 |
|
|
359.8 |
|
|
||
Diluted |
|
364.8 |
|
|
360.0 |
|
|
|
|
364.2 |
|
|
359.8 |
|
|
||
|
|
|
|
|
|
|
|
||||||||||
(A) Included in net sales, cost of sales and restructuring and other charges are the impacts of returns and charges associated with the restructuring program component of the PRGP and the Post-COVID Business Acceleration Program (the "PCBA Program"). Additional information about the restructuring program component of the PRGP and the PCBA Program is included in the notes to consolidated financial statements in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2025. |
|||||||||||||||||
(B) During the fiscal 2025 second quarter, the TOM FORD brand experienced lower-than-expected growth within key geographic regions and channels, including in mainland China, Asia travel retail and Hong Kong SAR. Also during the fiscal 2025 second quarter, the Too Faced reporting unit experienced lower-than-expected results in key geographic regions and channels. As a result, the Company made revisions to the internal forecasts relating to its TOM FORD brand and Too Faced reporting unit. Additionally, there were increases in the weighted average cost of capital for the TOM FORD brand and Too Faced reporting unit as compared to the prior-year annual goodwill and other indefinite-lived intangible asset impairment testing as of April 1, 2024. The Company concluded that the changes in circumstances in the TOM FORD brand and Too Faced reporting unit, along with increases in the weighted average cost of capital, triggered the need for interim impairment reviews of the TOM FORD trademark and the Too Faced trademark and goodwill. These changes in circumstances were also an indicator that the carrying amounts of Too Faced's long-lived assets, including customer lists, may not be recoverable. After performing the relevant impairment assessments, the Company recorded $773 million and $75 million of trademark intangible asset impairment charges for TOM FORD and Too Faced, respectively, as well as a $13 million goodwill impairment charge related to Too Faced. |
|||||||||||||||||
For the three and six months ended December 31, 2024, charges related to goodwill and other intangible asset impairments were $861 million ($674 million, net of tax), with an impact of $1.87 per common share. |
|||||||||||||||||
(C) From the end of August 2024 through October 2024, the Company reached agreements with certain plaintiff law firms (collectively, the "talcum litigation settlement agreements") for: (i) the resolution of pending cosmetic talcum powder matters handled by those firms as well as (ii) a process for resolving potential future cosmetic talcum powder claims expected to be brought on behalf of plaintiffs by those firms from January 1, 2025 through December 31, 2029, with annual capped amounts per year for each participating law firm. To account for the talcum litigation settlement agreements, the Company recorded a charge of $159 million in the fiscal 2025 first quarter for the amount agreed to settle the current claims and an estimated amount for potential future claims. |
|||||||||||||||||
Results by Product Category |
||||||||||||||||||||
(Unaudited) |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
|
Six Months Ended December 31 |
|||||||||||||||||||
|
Net Sales |
Percentage Change1 |
Operating Income (Loss) |
Percentage Change |
||||||||||||||||
($ in millions) |
2025 |
2024 |
Reported Basis |
Impact of Foreign Currency Translation |
Organic Net Sales (Non-GAAP) |
2025 |
2024 |
Reported Basis |
||||||||||||
Skin Care |
$ |
3,629 |
$ |
3,450 |
5 |
% |
(1 |
)% |
4 |
% |
$ |
641 |
|
$ |
423 |
|
52 |
% |
||
Makeup |
|
2,194 |
|
|
2,188 |
|
— |
|
(2 |
) |
(1 |
) |
|
3 |
|
|
(396 |
) |
100 |
+ |
Fragrance |
|
1,533 |
|
|
1,374 |
|
12 |
|
(2 |
) |
10 |
|
|
191 |
|
|
(386 |
) |
100 |
+ |
Hair Care |
|
297 |
|
|
298 |
|
— |
|
— |
|
(1 |
) |
|
6 |
|
|
(21 |
) |
100 |
+ |
Other |
|
56 |
|
|
55 |
|
2 |
|
— |
|
2 |
|
|
22 |
|
|
(34 |
) |
100 |
+ |
Subtotal |
$ |
7,709 |
|
$ |
7,365 |
|
5 |
% |
(1 |
)% |
3 |
% |
$ |
863 |
|
$ |
(414 |
) |
100 |
+% |
Returns/charges |
||||||||||||||||||||
associated with |
||||||||||||||||||||
restructuring and |
||||||||||||||||||||
other activities |
|
1 |
|
|
— |
|
|
|
|
|
(293 |
) |
|
(287 |
) |
|
||||
Total |
$ |
7,710 |
|
$ |
7,365 |
|
5 |
% |
(1 |
)% |
3 |
% |
$ |
570 |
|
$ |
(701 |
) |
100 |
+% |
Non-GAAP Adjustments to As Reported Operating Income (Loss): |
||||||||||||||||||||
Returns/charges associated with restructuring and other activities |
|
293 |
|
|
287 |
|
|
|||||||||||||
Makeup - Goodwill and other intangible asset impairments |
|
— |
|
|
258 |
|
|
|||||||||||||
Fragrance - Other intangible asset impairments |
|
— |
|
|
549 |
|
|
|||||||||||||
Other - Other intangible asset impairments |
|
— |
|
|
54 |
|
|
|||||||||||||
Makeup - Talcum litigation settlement agreements |
|
— |
|
|
159 |
|
|
|||||||||||||
Adjusted Operating Income - Non-GAAP |
$ |
863 |
|
$ |
606 |
|
42 |
% |
||||||||||||
1Percentages are calculated on an individual basis. |
||||||||||||||||||||
Results by Geographic Region |
||||||||||||||||||||
(Unaudited) |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
|
Six Months Ended December 31 |
|||||||||||||||||||
|
Net Sales |
Percentage Change1 |
Operating Income (Loss) |
Percentage Change |
||||||||||||||||
($ in millions) |
2025 |
2024 |
Reported Basis |
Impact of Foreign Currency Translation |
Organic Net Sales (Non-GAAP) |
2025 |
2024 |
Reported Basis |
||||||||||||
The Americas |
$ |
2,392 |
$ |
2,406 |
(1 |
)% |
— |
% |
(1 |
)% |
$ |
191 |
|
$ |
(856 |
) |
100 |
+% |
||
EUKEM |
|
2,084 |
|
|
1,953 |
|
7 |
|
(5 |
) |
1 |
|
|
162 |
|
|
155 |
|
5 |
|
Asia/Pacific |
|
1,773 |
|
|
1,694 |
|
5 |
|
1 |
|
5 |
|
|
350 |
|
|
228 |
|
54 |
|
Mainland China |
|
1,460 |
|
|
1,312 |
|
11 |
|
— |
|
11 |
|
|
160 |
|
|
59 |
|
100 |
+ |
Subtotal |
$ |
7,709 |
|
$ |
7,365 |
|
5 |
% |
(1 |
)% |
3 |
% |
$ |
863 |
|
$ |
(414 |
) |
100 |
+% |
Returns/charges |
||||||||||||||||||||
associated with |
||||||||||||||||||||
restructuring and other |
||||||||||||||||||||
activities |
|
1 |
|
|
— |
|
|
|
|
|
(293 |
) |
|
(287 |
) |
|
||||
Total |
$ |
7,710 |
|
$ |
7,365 |
|
5 |
% |
(1 |
)% |
3 |
% |
$ |
570 |
|
$ |
(701 |
) |
100 |
+% |
Non-GAAP Adjustments to As Reported Operating Income (Loss): |
||||||||||||||||||||
Returns/charges associated with restructuring and other activities |
|
293 |
|
|
287 |
|
|
|||||||||||||
The Americas - Goodwill and other intangible asset impairments |
|
— |
|
|
861 |
|
|
|||||||||||||
The Americas - Talcum litigation settlement agreements |
|
— |
|
|
159 |
|
|
|||||||||||||
Adjusted Operating Income - Non-GAAP |
$ |
863 |
|
$ |
606 |
|
42 |
% |
||||||||||||
1Percentages are calculated on an individual basis. |
||||||||||||||||||||
This earnings release includes some non-GAAP financial measures relating to charges associated with restructuring and other activities and adjustments, as well as organic net sales. Included herein are reconciliations between the non-GAAP financial measures and the most directly comparable GAAP measures for certain consolidated statements of earnings (loss) accounts before and after these items. The Company uses certain non-GAAP financial measures, among other financial measures, to evaluate its operating performance, which represent the manner in which the Company conducts and views its business. Management believes that excluding certain items that are not comparable from period-to-period, or do not reflect the Company's underlying ongoing business, provides transparency for such items and helps investors and others compare and analyze operating performance from period-to-period. In the future, the Company expects to incur charges or adjustments similar in nature to those presented herein; however, the impact to the Company's results in a given period may be highly variable and difficult to predict. The Company's non-GAAP financial measures may not be comparable to similarly titled measures used by, or determined in a manner consistent with, other companies. While the Company considers the non-GAAP measures useful in analyzing its results, they are not intended to replace, or act as a substitute for, any presentation included in the consolidated financial statements prepared in conformity with U.S. GAAP.
The Company operates on a global basis, with the majority of its net sales generated outside the United States. Accordingly, fluctuations in foreign currency exchange rates can affect the Company's results of operations. Therefore, the Company presents certain net sales information excluding the effect of foreign currency rate fluctuations to provide a framework for assessing the performance of its underlying business outside the United States. Constant currency information compares results between periods as if exchange rates had remained constant period-over-period. The Company calculates constant currency information by translating current-period results using prior-year period monthly average foreign currency exchange rates and adjusting for the period-over-period impact of foreign currency cash flow hedging activities.
Reconciliation between GAAP and Non-GAAP Net Sales |
||||||||||||||
(Unaudited) |
||||||||||||||
|
Three Months Ended December 31 |
Percentage Change |
Six Months Ended December 31 |
Percentage Change |
||||||||||
($ in millions) |
2025 |
2024 |
2025 |
2024 |
||||||||||
Net Sales |
$ |
4,229 |
|
$ |
4,004 |
6 |
% |
$ |
7,710 |
|
$ |
7,365 |
5 |
% |
Non-GAAP Adjustments |
|
|
|
|
|
|
||||||||
Returns associated with restructuring and other activities |
|
— |
|
|
— |
|
|
(1 |
) |
|
— |
|
||
Adjusted Net Sales, Non-GAAP |
|
4,229 |
|
|
4,004 |
|
|
7,709 |
|
|
7,365 |
|
||
Impact of foreign currency translation |
|
(74 |
) |
|
— |
|
(99 |
) |
|
— |
||||
Organic Net Sales, Non-GAAP |
$ |
4,155 |
|
$ |
4,004 |
4 |
% |
$ |
7,610 |
|
$ |
7,365 |
3 |
% |
Reconciliation of Certain Consolidated Statements of Earnings (Loss) Accounts |
||||||||||||||||
Before and After Returns, Charges and Other Adjustments |
||||||||||||||||
(Unaudited)1 |
||||||||||||||||
|
Three Months Ended December 31 |
Percentage Change |
Six Months Ended December 31 |
Percentage Change |
||||||||||||
($ in millions, except per share data) |
2025 |
2024 |
2025 |
2024 |
||||||||||||
Gross Profit |
$ |
3,235 |
|
$ |
3,047 |
|
6 |
% |
$ |
5,789 |
|
$ |
5,480 |
|
6 |
% |
Non-GAAP Adjustments |
|
|
|
|
|
|
||||||||||
Restructuring and other activities |
|
— |
|
|
— |
|
|
|
(3 |
) |
|
9 |
|
|
||
Adjusted Gross Profit, Non-GAAP |
|
3,235 |
|
|
3,047 |
|
6 |
% |
|
5,786 |
|
|
5,489 |
|
5 |
% |
Impact of foreign currency translation |
|
(51 |
) |
|
— |
|
|
|
(69 |
) |
|
— |
|
|
||
Adjusted Gross Profit, Non-GAAP constant currency |
$ |
3,184 |
|
$ |
3,047 |
|
4 |
% |
$ |
5,717 |
|
$ |
5,489 |
|
4 |
% |
|
|
|
|
|
|
|
||||||||||
Gross Margin |
|
76.5 |
% |
|
76.1 |
% |
|
|
75.1 |
% |
|
74.4 |
% |
|
||
Non-GAAP Adjustments |
|
|
|
|
|
|
||||||||||
Restructuring and other activities |
|
— |
|
|
— |
|
|
|
— |
|
|
0.1 |
|
|
||
Adjusted Gross Margin, Non-GAAP |
|
76.5 |
% |
|
76.1 |
% |
|
|
75.1 |
% |
|
74.5 |
% |
|
||
|
|
|
|
|
|
|
||||||||||
Operating Income (Loss) |
$ |
401 |
|
$ |
(580 |
) |
100 |
+% |
$ |
570 |
|
$ |
(701 |
) |
100 |
+% |
Non-GAAP Adjustments |
|
|
|
|
|
|
||||||||||
Restructuring and other charges |
|
207 |
|
|
181 |
|
|
|
293 |
|
|
287 |
|
|
||
Goodwill and other intangible asset impairments |
|
— |
|
|
861 |
|
|
|
— |
|
|
861 |
|
|
||
Talcum litigation settlement agreements |
|
— |
|
|
— |
|
|
|
— |
|
|
159 |
|
|
||
Adjusted Operating Income, Non-GAAP |
|
608 |
|
|
462 |
|
32 |
% |
|
863 |
|
|
606 |
|
42 |
% |
Impact of foreign currency translation |
|
(11 |
) |
|
— |
|
|
|
(8 |
) |
|
— |
|
|
||
Adjusted Operating Income, Non-GAAP constant currency |
$ |
597 |
|
$ |
462 |
|
29 |
% |
$ |
855 |
|
$ |
606 |
|
41 |
% |
|
|
|
|
|
|
|
||||||||||
Operating Margin |
|
9.5 |
% |
|
(14.5 |
)% |
|
|
7.4 |
% |
|
(9.5 |
)% |
|
||
Non-GAAP Adjustments |
|
|
|
|
|
|
||||||||||
Restructuring and other charges |
|
4.9 |
|
|
4.5 |
|
|
|
3.8 |
|
|
3.9 |
|
|
||
Goodwill and other intangible asset impairments |
|
— |
|
|
21.5 |
|
|
|
— |
|
|
11.7 |
|
|
||
Talcum litigation settlement agreements |
|
— |
|
|
— |
|
|
|
— |
|
|
2.2 |
|
|
||
Adjusted Operating Margin, Non-GAAP |
|
14.4 |
% |
|
11.5 |
% |
|
|
11.2 |
% |
|
8.2 |
% |
|
||
|
|
|
|
|
|
|
||||||||||
Provision (benefit) for Income Taxes |
$ |
171 |
|
$ |
(60 |
) |
100 |
+% |
$ |
233 |
|
$ |
(84 |
) |
100 |
+% |
Effective Tax Rate ("ETR") |
|
51.4 |
% |
|
9.2 |
% |
|
|
52.7 |
% |
|
10.1 |
% |
|
||
Tax Impact on Non-GAAP adjustments |
|
|
|
|
|
|
||||||||||
Restructuring and other charges |
|
44 |
|
|
40 |
|
|
|
61 |
|
|
62 |
|
|
||
Goodwill and other intangible asset impairments |
|
— |
|
|
187 |
|
|
|
— |
|
|
187 |
|
|
||
Talcum litigation settlement agreements |
|
— |
|
|
— |
|
|
|
— |
|
|
35 |
|
|
||
Adjusted Provision for Income Taxes, Non-GAAP |
$ |
215 |
|
$ |
167 |
|
|
$ |
294 |
|
$ |
200 |
|
|
||
Adjusted ETR, Non-GAAP |
|
39.8 |
% |
|
42.6 |
% |
|
|
40.0 |
% |
|
41.9 |
% |
|
||
|
|
|
|
|
|
|
||||||||||
Diluted Net Earnings (Loss) Per Common Share |
$ |
.44 |
|
$ |
(1.64 |
) |
100 |
+% |
$ |
.57 |
|
$ |
(2.07 |
) |
100 |
+% |
Non-GAAP Adjustments |
|
|
|
|
|
|
||||||||||
Restructuring and other charges |
|
.45 |
|
|
.39 |
|
|
|
.64 |
|
|
.63 |
|
|
||
Goodwill and other intangible asset impairments |
|
— |
|
|
1.87 |
|
|
|
— |
|
|
1.87 |
|
|
||
Talcum litigation settlement agreements |
|
— |
|
|
— |
|
|
|
— |
|
|
.34 |
|
|
||
Adjusted Diluted Net Earnings Per Common Share, Non-GAAP2 |
$ |
.89 |
|
$ |
.62 |
|
43 |
% |
$ |
1.21 |
|
$ |
.77 |
|
58 |
% |
Impact of foreign currency translation |
|
(.02 |
) |
|
— |
|
|
|
(.01 |
) |
|
— |
|
|
||
Adjusted Diluted Net Earnings Per Common Share, Non-GAAP constant currency2 |
$ |
.87 |
|
$ |
.62 |
|
40 |
% |
$ |
1.20 |
|
$ |
.77 |
|
56 |
% |
1Percentages are calculated on an individual basis. |
||||||||||||||||
2For the three and six months ended December 31, 2024 the effects of potentially dilutive stock options, performance share units, and restricted stock units of approximately 1.1 million shares and 1.2 million shares, respectively, were excluded from the computation of As Reported and adjustments to Non-GAAP diluted loss per common share as they were anti-dilutive due to the net loss incurred during the periods. These shares were added to the weighted-average common shares outstanding to calculate Non-GAAP diluted earnings per common share. |
||||||||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
|||||||||
(Unaudited, except where noted) |
|||||||||
|
|
|
|
||||||
|
December 31, 2025 |
June 30, 2025 |
December 31, 2024 |
||||||
($ in millions) |
(Audited) |
||||||||
ASSETS |
|
|
|
||||||
|
|
|
|
||||||
Cash and cash equivalents |
$ |
3,082 |
$ |
2,921 |
$ |
2,586 |
|||
Accounts receivable, net |
|
1,657 |
|
|
1,530 |
|
|
1,611 |
|
Inventory and promotional merchandise |
|
1,895 |
|
|
2,074 |
|
|
2,002 |
|
Prepaid expenses and other current assets |
|
524 |
|
|
544 |
|
|
697 |
|
Total current assets |
|
7,158 |
|
|
7,069 |
|
|
6,896 |
|
Property, plant and equipment, net |
|
2,966 |
|
|
3,172 |
|
|
3,049 |
|
Operating lease right-of-use assets |
|
1,860 |
|
|
1,952 |
|
|
1,891 |
|
Other assets |
|
7,650 |
|
|
7,699 |
|
|
7,924 |
|
Total assets |
$ |
19,634 |
|
$ |
19,892 |
|
$ |
19,760 |
|
|
|
|
|
||||||
LIABILITIES AND EQUITY |
|
|
|
||||||
|
|
|
|
||||||
Current debt |
$ |
3 |
|
$ |
3 |
|
$ |
4 |
|
Accounts payable |
|
1,260 |
|
|
1,497 |
|
|
1,133 |
|
Operating lease liabilities |
|
413 |
|
|
406 |
|
|
397 |
|
Other accrued liabilities |
|
3,595 |
|
|
3,529 |
|
|
3,497 |
|
Total current liabilities |
|
5,271 |
|
|
5,435 |
|
|
5,031 |
|
Long-term debt |
|
7,319 |
|
|
7,314 |
|
|
7,276 |
|
Long-term operating lease liabilities |
|
1,655 |
|
|
1,744 |
|
|
1,706 |
|
Other noncurrent liabilities |
|
1,358 |
|
|
1,534 |
|
|
1,578 |
|
Total noncurrent liabilities |
|
10,332 |
|
|
10,592 |
|
|
10,560 |
|
Total equity |
|
4,031 |
|
|
3,865 |
|
|
4,169 |
|
Total liabilities and equity |
$ |
19,634 |
|
$ |
19,892 |
|
$ |
19,760 |
|
SELECT CASH FLOW DATA |
||||||
(Unaudited) |
||||||
|
|
|
||||
|
Six Months Ended December 31 |
|||||
($ in millions) |
2025 |
2024 |
||||
Net earnings (loss) |
$ |
209 |
|
$ |
(746 |
) |
Adjustments to reconcile net earnings (loss) to net cash flows from operating |
|
|
||||
activities: |
||||||
Depreciation and amortization |
|
397 |
|
|
415 |
|
Deferred income taxes |
|
11 |
|
|
(292 |
) |
Impairment of goodwill and other intangible assets |
|
— |
|
|
861 |
|
Other items |
|
192 |
|
|
193 |
|
Changes in operating assets and liabilities: |
|
|
||||
(Increase) decrease in accounts receivable, net |
|
(126 |
) |
|
79 |
|
Decrease in inventory and promotional merchandise |
|
179 |
|
|
132 |
|
Decrease (increase) in other assets, net |
|
25 |
|
|
(47 |
) |
Decrease in accounts payable and other liabilities, net |
|
(102 |
) |
|
(208 |
) |
Net cash flows provided by operating activities |
$ |
785 |
|
$ |
387 |
|
|
|
|
||||
Other Investing and Financing Uses: |
|
|
||||
Capital expenditures |
$ |
(204 |
) |
$ |
(273 |
) |
Repayments of long-term debt, net |
|
(2 |
) |
|
(502 |
) |
Dividends paid to stockholders |
|
(255 |
) |
|
(366 |
) |
Payment of deferred consideration |
|
(150 |
) |
|
— |
|
|
|
|
||||
Supplemental cash flow information: |
|
|
||||
Cash paid for interest |
$ |
168 |
|
$ |
179 |
|
Cash paid for income taxes |
|
295 |
|
|
327 |
|
Reconciliation of Certain Consolidated Statements of Cash Flows Accounts |
||||||
Cash Flows from Operating Activities to Free Cash Flow |
||||||
|
|
|
||||
|
Six Months Ended December 31 |
|||||
($ in millions) |
2025 |
2024 |
||||
Net cash flows provided by operating activities |
$ |
785 |
|
$ |
387 |
|
Less: capital expenditures |
|
(204 |
) |
|
(273 |
) |
Free cash flow |
$ |
581 |
|
$ |
114 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20260205919487/en/
Investors: Rainey Mancini rmancini@estee.com
Media: Brendan Riley briley@estee.com